Further evaluation of non-canonical osteoclast activation and HE is warranted; nonetheless, our result suggests that between c-Fos and NF-κB activation changes via HE exposure, the result is a significant inhibition of osteoclast development. The gene discussed is FOS; the disease is hereditary elliptocytosis.